Withdrawal of Left Ventricular Assist Devices: A Retrospective Analysis from a Single Institution

被引:24
作者
Nakagawa, Shunichi [1 ]
Ando, Masahiko [2 ]
Takayama, Hiroo [3 ]
Takeda, Koji [3 ]
Garan, Arthur R. [4 ]
Yuill, Lauren [5 ]
Rosen, Amanda [6 ]
Topkara, Veli K. [4 ]
Yuzefpolskaya, Melana [4 ]
Colombo, Paolo C. [4 ]
Naka, Yoshifumi [3 ]
Blinderman, Craig D. [1 ]
机构
[1] Columbia Univ, Dept Med, Med Ctr, Adult Palliat Care, 601 West 168th St,Suite 37, New York, NY 10032 USA
[2] Univ Tokyo, Div Cardiothorac Surg, Dept Surg, Tokyo, Japan
[3] Columbia Univ, Dept Surg, Med Ctr, Div Cardiothorac Surg, New York, NY USA
[4] Columbia Univ, Dept Med, Med Ctr, Div Cardiol, New York, NY USA
[5] NewYork Presbyterian Hosp, Dept Care Coordinat & Social Work, Adult Palliat Care, New York, NY USA
[6] Columbia Univ, Dept Med, Med Ctr, New York, NY USA
关键词
end-of-life care; left ventricular assist device; mechanical circulatory support; palliative care; withdrawal; LIFE-SUSTAINING THERAPIES; END; PERSPECTIVES;
D O I
10.1089/jpm.2019.0322
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: When left ventricular assist device (LVAD) therapy no longer is able to achieve patients' desired quality of life, withdrawal of LVAD therapy (WLVAD) may be requested. Objectives: To evaluate factors associated with WLVAD, including the time taken before WLVAD. Setting/Subjects: Sixty-two patients who newly underwent initial LVAD therapy during January 1, 2010 and October 30, 2018 and subsequently underwent WLVAD by December 31, 2018 were divided into those who participated in the decision of WLVAD (defined as PT+, n = 14), and those who could not participate in the decision because of the medical reasons (defined as PT-, n = 48). Measurements: Time to WLVAD in PT+ and PT- was defined as WD_PT+ (days between patients' request and WLVAD) and WD_PT- (days between when patients became unable to express themselves and WLVAD), respectively. Circumstances around WLVAD, including location of death and use of palliative care (PC), were reviewed. Results: Mean age at WLVAD was 65.4 +/- 10.1 years and 52 (83.9%) were men. Median days on LVAD support was 166.5 days (interquartile range = 838). The majority of WLVAD occurred in the intensive care unit (ICU) (83.6%) but less frequent in PT+ than in PT- (64.3% vs. 89.4%, p = 0.041). The median number of PC visits in the last month was higher in PT+ than in PT- (4.5 vs. 0.5, p = 0.005). The median WD_PT+ was 5.5 days and was significantly shorter in the ICU (1 day vs. 46 days, p = 0.013). The median WD_PT- was 5.5 days and tended to be shorter in the ICU (4 days vs. 13 days, p = 0.072). A multivariate analysis showed that male gender and ICU setting were both negatively associated with WD_PT- (p = 0.025 for men, p = 0.005 for ICU setting). Conclusions: The majority of WLVAD occurred in the ICU and required PC involvement. Time to WLVAD was shorter in the ICU. Requests for WLVAD directly made by patients, especially in a non-ICU setting, seemed to have posed more difficulty.
引用
收藏
页码:368 / 374
页数:7
相关论文
共 21 条
[1]   Dying With a Left Ventricular Assist Device as Destination Therapy [J].
Dunlay, Shannon M. ;
Strand, Jacob J. ;
Wordingham, Sara E. ;
Stulak, John M. ;
Luckhardt, Angela J. ;
Swetz, Keith M. .
CIRCULATION-HEART FAILURE, 2016, 9 (10)
[2]  
Huffman Jeff C., 2003, Prim Care Companion J Clin Psychiatry, V5, P177
[3]   Perspectives on Withdrawing Pacemaker and Implantable Cardioverter-Defibrillator Therapies at End of Life: Results of a Survey of Medical and Legal Professionals and Patients [J].
Kapa, Suraj ;
Mueller, Paul S. ;
Hayes, David L. ;
Asirvatham, Samuel J. .
MAYO CLINIC PROCEEDINGS, 2010, 85 (11) :981-990
[4]   Eighth annual INTERMACS report: Special focus on framing the impact of adverse events [J].
Kirklin, James K. ;
Pagani, Francis D. ;
Kormos, Robert L. ;
Stevenson, Lynne W. ;
Blume, Elizabeth D. ;
Myers, Susan L. ;
Miller, Marissa A. ;
Baldwin, J. Timothy ;
Young, James B. ;
Naftel, David C. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (10) :1080-1086
[5]  
Ko D.N., 2015, Oxford textbook of palliative medicine, V5A, P323
[6]   Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: A quantitative assessment [J].
Kramer, Daniel B. ;
Kesselheim, Aaron S. ;
Brock, Dan W. ;
Maisel, William H. .
HEART RHYTHM, 2010, 7 (11) :1537-1542
[7]   HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy [J].
Lampert, Rachel ;
Hayes, David L. ;
Annas, George J. ;
Farley, Margaret A. ;
Goldstein, Nathan E. ;
Hamilton, Robert M. ;
Kay, G. Neal ;
Kramer, Daniel B. ;
Mueller, Paul S. ;
Padeletti, Luigi ;
Pozuelo, Leo ;
Schoenfeld, Mark H. ;
Vardas, Panos E. ;
Wiegand, Debra L. ;
Zellner, Richard .
HEART RHYTHM, 2010, 7 (07) :1008-1026
[8]   End of life for patients with left ventricular assist devices: Insights from INTERMACS [J].
McIlvennan, Colleen K. ;
Grady, Kathleen L. ;
Matlock, Daniel D. ;
Helmkamp, Laura J. ;
Abshire, Martha ;
Allen, Larry A. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04) :374-381
[9]   Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice/Palliative Medicine Clinicians [J].
Mcilvennan, Colleen K. ;
Wordingham, Sara E. ;
Allen, Larry A. ;
Matlock, Daniel D. ;
Jones, Jacqueline ;
Dunlay, Shannon M. ;
Swetz, Keith M. .
JOURNAL OF CARDIAC FAILURE, 2017, 23 (09) :708-712
[10]   Lack of Agreement With What We Think Is Right Does Not Necessarily Equal an Ethical Problem: Respecting Patients' Goals of Care [J].
McIlvennan, Colleen K. ;
Swetz, Keith M. .
AMERICAN JOURNAL OF BIOETHICS, 2016, 16 (08) :13-15